Skip to main content

Published locations for RA: No increased risk for malignancy with tofacitinib vs. TNFi in real world

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. RA: No increased risk for malignancy with tofacitinib vs. TNFi in real world

User login

  • Reset your password
  • /content/ra-no-increased-risk-malignancy-tofacitinib-vs-tnfi-real-world
  • /rheumatology/article/255905/rheumatoid-arthritis/ra-no-increased-risk-malignancy-tofacitinib-vs-tnfi